Correlation Between Estrella Immunopharma and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Estrella Immunopharma and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Estrella Immunopharma and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Estrella Immunopharma and X4 Pharmaceuticals, you can compare the effects of market volatilities on Estrella Immunopharma and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Estrella Immunopharma with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Estrella Immunopharma and X4 Pharmaceuticals.
Diversification Opportunities for Estrella Immunopharma and X4 Pharmaceuticals
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Estrella and XFOR is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Estrella Immunopharma and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Estrella Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Estrella Immunopharma are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Estrella Immunopharma i.e., Estrella Immunopharma and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Estrella Immunopharma and X4 Pharmaceuticals
Assuming the 90 days horizon Estrella Immunopharma is expected to generate 4.45 times more return on investment than X4 Pharmaceuticals. However, Estrella Immunopharma is 4.45 times more volatile than X4 Pharmaceuticals. It trades about 0.19 of its potential returns per unit of risk. X4 Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest 3.62 in Estrella Immunopharma on September 1, 2024 and sell it today you would earn a total of 5.48 from holding Estrella Immunopharma or generate 151.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 39.68% |
| Values | Daily Returns |
Estrella Immunopharma vs. X4 Pharmaceuticals
Performance |
| Timeline |
| Estrella Immunopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
OK
| X4 Pharmaceuticals |
Estrella Immunopharma and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Estrella Immunopharma and X4 Pharmaceuticals
The main advantage of trading using opposite Estrella Immunopharma and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Estrella Immunopharma position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| Estrella Immunopharma vs. Tff Pharmaceuticals | Estrella Immunopharma vs. Eliem Therapeutics | Estrella Immunopharma vs. Inhibrx | Estrella Immunopharma vs. Enliven Therapeutics |
| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Correlations Find global opportunities by holding instruments from different markets |